Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,790
+110 (0.75%)
At close: Feb 20, 2026

KRX:271980 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
51,80053,47632,99131,44625,9633,893
Short-Term Investments
4,1143,9802,667142.462,0402,695
Cash & Short-Term Investments
55,91457,45535,65831,58928,0036,588
Cash Growth
48.79%61.13%12.88%12.80%325.06%-51.27%
Accounts Receivable
138,060160,467150,955137,807129,424141,176
Other Receivables
3,62513,44015,17115,45415,26515,747
Receivables
141,685173,908166,126153,262146,689156,922
Inventory
99,190104,427109,76899,151102,458109,311
Prepaid Expenses
230.98214.62327.84291.88186.71167.88
Other Current Assets
15,3177,0315,1677,3487,3364,524
Total Current Assets
312,338343,036317,046291,641284,672277,513
Property, Plant & Equipment
147,281146,166137,041138,402125,710115,547
Long-Term Investments
17,1388,3427,3436,7985,0321,920
Other Intangible Assets
8,8944,9944,3203,8883,7624,095
Long-Term Accounts Receivable
00-000-
Long-Term Deferred Tax Assets
7,4427,4285,359172.391,4523,321
Long-Term Deferred Charges
7,0328,3788,5615,494--
Other Long-Term Assets
1,5357,3567,65610,4965,8587,267
Total Assets
501,659525,700487,326456,892426,486409,663
Accounts Payable
81,882134,562144,338151,641153,084143,363
Accrued Expenses
178.33178.21160.7499.9129.3324.88
Short-Term Debt
89,52371,00064,77240,57624,16630,419
Current Portion of Long-Term Debt
---2,5006,1256,125
Current Portion of Leases
1,9171,9711,9461,8321,9151,598
Current Income Taxes Payable
3,6733,588448.241,049114.573,432
Other Current Liabilities
63,99680,39192,71062,66736,50933,096
Total Current Liabilities
241,169291,690304,375260,366221,943218,058
Long-Term Debt
---3,9998,9777,656
Long-Term Leases
1,4622,7254,4525,4436,6173,506
Pension & Post-Retirement Benefits
15,34211,7716,73325.041,2627,504
Other Long-Term Liabilities
94.11197.01938.5223,17020,339459.46
Total Liabilities
258,067306,383316,499293,003259,139237,184
Common Stock
7,3527,3527,3527,3527,3527,352
Additional Paid-In Capital
206,610206,223155,296155,296155,296149,117
Retained Earnings
-36,276-52,296-19,660-20,321-10,4142,841
Treasury Stock
-4,829-4,829-4,829-4,829-4,432-3,622
Comprehensive Income & Other
31,68431,69920,41020,41020,41016,706
Total Common Equity
204,542188,150158,570157,909168,213172,394
Minority Interest
39,04931,167-1,538-2,312-866.1685.04
Shareholders' Equity
243,591219,317170,828163,889167,347172,479
Total Liabilities & Equity
501,659525,700487,326456,892426,486409,663
Total Debt
92,90275,69571,17054,35047,80049,304
Net Cash (Debt)
-36,988-18,240-35,513-22,761-19,797-42,716
Net Cash Per Share
-2538.41-1251.75-2437.13-1561.68-1355.11-2922.88
Filing Date Shares Outstanding
14.5714.5714.5714.5714.5814.61
Total Common Shares Outstanding
14.5714.5714.5714.5714.5814.61
Working Capital
71,16951,34512,67131,27562,72959,455
Book Value Per Share
14037.0912912.1610882.2010836.8311533.5211800.20
Tangible Book Value
195,648183,156154,250154,021164,451168,299
Tangible Book Value Per Share
13426.7412569.4410585.7110570.0211275.5611519.87
Land
54,46153,69840,61340,58630,10623,821
Buildings
67,675105,484103,864103,864102,213102,747
Machinery
11,10488,78788,62282,31576,56072,000
Construction In Progress
-4,7243,0703,7172,390584.93
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.